Total Equity - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Total Equity Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Total Equity
ÂŁ14.4B
CAGR 3-Years
-2%
CAGR 5-Years
32%
CAGR 10-Years
9%
A
AstraZeneca PLC
NASDAQ:AZN
Total Equity
$39.5B
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Total Equity
-$121m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Equity
$2.3B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
7%
Allergy Therapeutics PLC
LSE:AGY
Total Equity
ÂŁ26.5m
CAGR 3-Years
-23%
CAGR 5-Years
-10%
CAGR 10-Years
2%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Equity
ÂŁ755.2m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
16%

See Also

What is GlaxoSmithKline PLC's Total Equity?
Total Equity
14.4B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Total Equity amounts to 14.4B GBP.

What is GlaxoSmithKline PLC's Total Equity growth rate?
Total Equity CAGR 10Y
9%

Over the last year, the Total Equity growth was 13%. The average annual Total Equity growth rates for GlaxoSmithKline PLC have been -2% over the past three years , 32% over the past five years , and 9% over the past ten years .

Back to Top